# Safety and Efficacy Study of TRO40303 for Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction

> **NCT01374321** · PHASE2 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 168 (actual)

## Conditions studied

- Acute Myocardial Infarctus

## Interventions

- **DRUG:** TRO40303
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01374321
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2018-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01374321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01374321, "Safety and Efficacy Study of TRO40303 for Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01374321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*